Edition:
United States

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,808JPY
20 Jul 2018
Change (% chg)

¥0 (+0.03%)
Prev Close
¥1,808
Open
¥1,817
Day's High
¥1,827
Day's Low
¥1,794
Volume
5,857,500
Avg. Vol
7,571,683
52-wk High
¥1,835
52-wk Low
¥1,336

Summary

Name Age Since Current Position

Yoshihiko Hatanaka

61 2018 Chairman of the Board, Chairman of the Board of Directors, Representative Director

Kenji Yasukawa

57 2018 President, Chief Executive Officer, Representative Director

Chikashi Takeda

2017 Chief Financial Officer, Executive Officer

Bernhardt Zeiher

2018 President - Development, Chief Medical Officer

Fumiaki Sakurai

2017 Chief Administrative Officer, Chief Ethics & Compliance Officer, Executive Officer

Nate Crisel

2017 Vice President - Real World Informatics & Analytics

Linda Friedman

2017 General Counsel

Masatoshi Kuroda

2017 Senior Executive Officer, Chief Director of Asia & Oceania Business

Mitsunori Matsuda

2017 Senior Executive Officer, Chief Director of Pharmaceutical Technology

Makoto Takeuchi

2015 Senior Executive Officer, Director of External Affairs

Wataru Uchida

2015 Senior Executive Officer, Chief Director of Research

Chihiro Yokota

2015 Senior Executive Officer, Chief Director of Development

Nobuaki Tanaka

2016 Executive Officer, Chief Director of Sales

Tadashi Hara

2017 Executive Officer, Director of Sales Strategy in Main Sales Unit

Akihiko Iwai

2017 Executive Officer, Director of Candidate Discovery Research Institute in Main Research Unit

Atsushi Kamide

2016 Executive Officer, Director of Health Policy

Yasuhiro Kanzaki

2016 Executive Officer, Manager of Osaka Office in Main Sales Unit

Yukio Matsui

2016 Executive Officer, Manager of Europe & Middle East & Africa Business

Eisuke Nozawa

Executive Officer, Director of Pharmaceutical Affairs

Naoki Okamura

2016 Executive Officer, Director of Business Planning

Kazunori Okimura

2016 Executive Officer, Director of Legal Affairs

Takuya Oshida

2016 Executive Officer, Chief Director of Medical Affairs

Katzumi Ozawa

Executive Officer, Manager of Tokyo Office in Main Sales Unit

Kazuhiro Sako

Executive Officer, President of Subsidiary

Taiji Sawamoto

2017 Executive Officer, Director of Research Program Promotion in Main Research Unit

Hideki Shima

2017 Executive Officer, Director of Technology Planning in Main Pharmaceutical Technology Unit

Shigeki Tanaka

2017 Executive Officer, Director of 1st Japan & Asia Clinical Development in Main Development Unit

Toru Yoshimitsu

2017 Executive Officer, Director of Business Promotion

Sef Kurstjens

2017 Chief Medical Officer

Tomokazu Fujisawa

2018 Director

Hiroko Sakai

2018 Director

Yoshiharu Aizawa

71 2015 Independent Director

Hitoshi Kanamori

2018 Independent Director

Hiroo Sasaki

62 2018 Independent Director

Mamoru Sekiyama

67 2017 Independent Director

Noriyuki Uematsu

2018 Independent Director

Keiko Yamagami

56 2017 Independent Director

Akira Kamimura

2017 Director of Accounting

Biographies

Name Description

Yoshihiko Hatanaka

Mr. Yoshihiko Hatanaka has been serving as Chairman of the Board, Chairman of the Board of Directors and Representative Director in Astellas Pharma Inc. since April 1, 2018. His previous titles include Executive Officer and Senior Executive Officer in the Company. He previously served as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.

Kenji Yasukawa

Mr. Kenji Yasukawa has been serving as President, Chief Executive Officer and Representative Director in Astellas Pharma Inc. since April 1, 2018. He joined the Company in April 1986. His previous titles include Executive Officer, Senior Executive Officer and Director of Product Strategy in the Company. He used to work for Yamanouchi Pharmaceutical Co., Ltd. and a subsidiary.

Chikashi Takeda

Bernhardt Zeiher

Mr. Bernhardt G. Zeiher, M.D., F.C.C.P., F.A.C.P., is President - Development, Chief Medical Officer of the Company. Zeiher started his career at Astellas in 2010 as vice president and Therapeutic Area leader for Inflammation, Immunology and Infectious Diseases. He was promoted to senior vice president and Therapeutic Area Head for Immunology, Infectious Diseases and Transplant in 2012. Zeiher was later named executive vice president and Therapeutic Area Head when his organization was expanded to include the company's CNS and Pain programs. Most recently, Zeiher was promoted to president of Development in 2015. Prior to joining Astellas, Zeiher served as the vice president of the Inflammation/Immunology therapeutic area at Pfizer. He earned his Doctor of Medicine at the Case Western Reserve University School of Medicine, and completed an internal medicine residency at University Hospitals of Clevelandas well as a fellowship in Pulmonary and Critical Care Medicine at University of IowaHospitals and Clinics. Zeiher is a Fellow in the American College of Physicians and the American College of Chest Physicians. He has worked in the pharmaceutical industry since 1998.

Fumiaki Sakurai

Nate Crisel

Mr. Nate Crisel is Vice President - Real World Informatics & Analytics of the Company. Nate's background at Astellas includes roles in New Product Analysis and nearly four years at ourTokyoheadquarters in Product and Portfolio Strategy and Corporate Planning divisions," said Takeda. " It was in his role in Corporate Planning where he initiated the idea of having the RWI Center of Excellence. He then proceeded to build the organization from scratch to its current state." Crisel will continue to be responsible for overseeing the RWI division, a central function accountable for expanding efficient, effective and compliant use of healthcare data across the entire Astellas value chain. Prior to joining Astellas in 2008, Crisel served as an analytical chemist and pharmaceutical development project manager at Eli Lilly and Company (Lilly). After Lilly, he held roles ranging from business development and executive leadership at biotech start-ups, including Embedded Concepts, LLC, and Tracera, LLC. Crisel received a Master of Business Administration in finance and entrepreneurship from Purdue University's Krannert School of Management and a Bachelor of Science in chemistry from Indiana University.

Linda Friedman

Masatoshi Kuroda

Mitsunori Matsuda

Makoto Takeuchi

Wataru Uchida

Chihiro Yokota

Nobuaki Tanaka

Tadashi Hara

Akihiko Iwai

Atsushi Kamide

Yasuhiro Kanzaki

Yukio Matsui

Eisuke Nozawa

Naoki Okamura

Kazunori Okimura

Takuya Oshida

Katzumi Ozawa

Kazuhiro Sako

Taiji Sawamoto

Hideki Shima

Shigeki Tanaka

Toru Yoshimitsu

Sef Kurstjens

Tomokazu Fujisawa

Hiroko Sakai

Yoshiharu Aizawa

Mr. Yoshiharu Aizawa has been serving as Independent Director in Astellas Pharma Inc. since June 2015. He is also an Honorary Professor of Kitasato University. He used to work for Keio University.

Hitoshi Kanamori

Hiroo Sasaki

Mr. Hiroo Sasaki was named Independent Director in Astellas Pharma Inc. effective June 15, 2018. He will be also a member of Audit Committee of the Company. He is also a Professor of Waseda University. He used to work for Nagoya City University and Ministry of Finance, Japan.

Mamoru Sekiyama

Mr. Mamoru Sekiyama has been serving as Independent Director in Astellas Pharma Inc. since June 19, 2017. He is also working for Marubeni Corporation. He used to work for Marubeni Power Systems Corporation.

Noriyuki Uematsu

Keiko Yamagami

Ms. Keiko Yamagami has been serving as Independent Director in Astellas Pharma Inc. since June 19, 2017. She is also working for Tokyo Seiwa Law Office. She used to work for Ministry of Justice, Japan.

Akira Kamimura